Advertisement
News
Advertisement

Ensemble Therapeutics lands two new patent claims

Wed, 07/06/2011 - 11:36am
Mass High Tech: The Journal of New England Technology

The U.S. Patent and Trademark Office has allowed two new claims relating to patents Ensemble Therapeutics has licensed exclusively from Harvard University, bringing to 53 the total number of issued or allowed patents the Cambridge biotech has worldwide.

The new claims cover broad and fundamental aspects of Ensemble’s DNA-Programmed Chemistry (DPC) molecular library platform used for drug discovery.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading